Login

Assessing Austria's IT Industry in Global Competition | Helmut Fallmann , CEO of Fabasoft AG 00:10:00

Share On Facebook Share On Twitter

Helmut Fallmann is Chairman-Mgmt Board/CEO/Founder at Fabasoft AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Are Your Emotions or Finances in Control? Let's Talk.
00:10:00
The Power of Purpose in Entrepreneurship|William Crowder,Managing Partner,Aperture Venture Capital
00:10:00
Either you've found this hidden gold pile in the dirt somewhere or else it|Evan Moore,General Partner, Khosla Ventures
00:10:00
Exploring Peru's Rich Mining Potential: Pucara's High-Sulfidation Gold Prospects
00:10:00
DST Global's Yuri Milner Discusses Breakthrough Listen and Extraterrestrial Exploration | Yuri Milner, Founder, DST Global.
00:10:00
Fearless Films: Empowering Regional Filmmakers with Feros Care
00:10:00
Peter Harrison, CEO of Schroders, discusses market outlooks with Bloomberg's Dani Burger at the Bloomberg Invest Global Summit.
00:00:00
Dr. David Sinclair, Professor in Genetics, Harvard Medical School
00:10:00
Navarre Minerals: Advancing Gold Discoveries in Victoria's Golden Triangle
00:10:00
Metals Australia Advances Lac Rainy Graphite Project| JON DUGDALE , Technical Advisor of Metals Australia Limited
00:10:00
Canadian North Resources: Recent Warrant Exercise and 2024 Outlook
00:10:00
Nick Planck Jonas Discusses Kalahari Gold's Growth Strategy and Market Outlook at One-to-One Mining Investment Conference

© 2017 - Neuhu+